ALT
#2820
Altimmune, Inc. - Common Stock
2.9 9 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.97%
Monthly Change
+14.12%
6 month change
-27.95%
Year Change
-30.30%
Previous Close
3.0 5
Open
2.9 9
Low
2.9 9
High
2.9 9
Volume
77
Financials
- Market Capitalization 581.48 M
- Employee 57
- Founded 1997
- CEO Jerry Durso
- Website www.altimmune.com
- Headquarter Delaware, United States
- FIGI BBG000FXML90
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.61
Price to sales ratio
7 757.46
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2794 |  NGNE Neurogene Inc. - Common Stock | 38.32 USD | -3.31% | +16.16% | +30.61% | +30.25% | 605.53 M USD | ||
| 2807 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 11.30 USD | -8.20% | -11.72% | +25.00% | 0.00% | 590.72 M USD | ||
| 2824 |  DRUG Bright Minds Biosciences Inc. - common stock | 75.93 USD | -2.45% | +11.88% | +22.76% | +192.49% | 579.79 M USD | ||
| 2835 |  IMMX Immix Biopharma, Inc. - Common Stock | 10.52 USD | -5.31% | -0.66% | +22.61% | +262.76% | 572.41 M USD |
Frequently asked questions about Altimmune, Inc. - Common Stock
What is the Altimmune, Inc. - Common Stock stock price today?
The current price of Altimmune, Inc. - Common Stock (ALT) is 2.99. Over the past 24 hours, the stock has changed by -1.97%. Follow the ALT chart for real-time price dynamics.
What is the stock ticker of Altimmune, Inc. - Common Stock?
Altimmune, Inc. - Common Stock trades under the ticker ALT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Altimmune, Inc. - Common Stock stock going up?
ALT has changed by -2.92% over the last week, +14.12% over the last month, and -30.30% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Altimmune, Inc. - Common Stock net income for the last quarter?
Altimmune, Inc. - Common Stock reported net income of -22.56 M for the last quarter. The previous quarter showed -27.36 M, which means net income changed by +17.53%.
How many employees does Altimmune, Inc. - Common Stock have?
As of the latest available data, Altimmune, Inc. - Common Stock has 57 employees. Workforce size can provide additional context about the company's scale and operations.
What is Altimmune, Inc. - Common Stock EBITDA?
Altimmune, Inc. - Common Stock EBITDA is -25.03 M, and its EBITDA margin is 16.25 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Altimmune, Inc. - Common Stock stock?
You can buy Altimmune, Inc. - Common Stock (ALT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Altimmune, Inc. - Common Stock stock?
Investing in Altimmune, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALT chart and related analysis on metatrader.com as part of your research.